UNSPSC 51302307: Croconazole

This classification denotes an antifungal agent with the molecular formula C18H15CLN2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 446254H55G. European Medicines Agency schedules croconazole in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06821MIG. The term CROCONAZOLE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 40, no. 6, 1986, list 26. ).

CROCONAZOLE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule croconazole under HS 29332990 and SITC 51573. As of Q4 2014, CROCONAZOLE remains the US FDA Preferred Term for this commodity. Croconazole bears US NLM identifiers UMLS ID C0056504 and NCI Concept Code C78037. SMILES: C=C(C1=CC=CC=C1OCC2=CC(=CC=C2)CL)N3C=CN=C3.

UNSPSC 51302307 Croconazole, a Commodity code, shows a sharp mismatch between its nominal scope and state and local procurement activity. The code nominally covers croconazole, an antifungal chemical compound, but the two recent opportunities posted under this code involve liquid aluminum sulfate for wastewater treatment phosphorus removal and medical aid supplies for fire rescue operations—neither of which relate to croconazole. The City of Austin's IFB for liquid aluminum sulfate specifies 47%-49% concentration unpackaged product delivered to its wastewater treatment facility to remove soluble phosphorus from activated sludge, with an estimated annual quantity of 179,200 gallons and NSF and AWWA B403 compliance required. The City of Tampa's ITB for medical aid supplies covers 32 first aid and emergency items including antiseptic sprays, hydrogen peroxide, bandages, and emergency blankets for its Fire Rescue Department, with an estimated budget of $100,000 and a one-year initial award period plus two optional renewals. These opportunities suggest the code is being used inconsistently or erroneously by the issuing jurisdictions.

Issuing bodies active under this code are city governments—the City of Austin and the City of Tampa—each posting a single recent opportunity. Geographic activity is limited to Texas and Florida based on available records. The Austin opportunity, posted July 27, 2026 with bids due August 25, 2026, applies local and small business preference discounts of 5% and 3% on bids under and above $500,000 respectively, requires manufacturer or authorized dealer status, mandates a minimum inventory of 9,000 gallons at distribution locations with a primary facility within 500 miles of Austin, and specifies firm pricing for 12 months with maximum 25% adjustments thereafter. The Tampa opportunity, posted April 24, 2026, includes set-aside provisions for City-certified Small Local Business Enterprises (SLBEs) and Underutilized Woman and Minority Owned Business Enterprises (U-WMBEs) with 5% bid discounts capped at $10,000 for SLBEs and $20,000 for U-WMBEs. Because the posted opportunities do not reflect the code's stated scope, this code shows little relevant recent activity for businesses in the croconazole space.